Article
From structural design to delivery: mRNA therapeutics for cancer immunotherapy
17 Nov 2023
Abstract excerpt
mRNA therapeutics have emerged as powerful tools for cancer immunotherapy in accordance with their superiority in expressing all sequence-known proteins in vivo. In particular, with a small dosage of delivered mRNA, antigen-presenting cells (APCs) can synthesize mutant neo-antigens and multi-antigens and present epitopes to T lymphocytes to elicit antitumor effects. In addition, expressing receptors like chimeric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
